The effect of methylprednisolone on intracellular calcium of normal and dystrophic human skeletal muscle cells

Neuroscience Letters

Volumn 269, Issue 2, 1999, Pages 110-114

  Vandebrouck, Clarisse ^a   Imbert, Nathalie ^a   Duport, Gérard ^b   Cognard, Christian ^a   Raymond, Guy ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Duchenne muscular dystrophy; Glucocorticoid; Human muscle; Intracellular calcium

Indexed keywords

ACETYLCHOLINE; CAFFEINE; CALCIUM ION; INDO 1; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHILD; COCULTURE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO; HUMAN; HUMAN CELL; MUSCLE FUNCTION; MUSCLE STRENGTH; MYOBLAST; MYOTUBE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ADOLESCENT; ADULT; CALCIUM; CHILD; CHILD, PRESCHOOL; GLUCOCORTICOIDS; HUMANS; INTRACELLULAR FLUID; METHYLPREDNISOLONE; MICROSCOPY, PHASE-CONTRAST; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES;

EID: 0033538558     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00418-8     Document Type: Article

References (22)

1. Askanas V., Cave S., Martinuzzi A., Engel W.K. Glucocorticoids increase number of acetylcholine receptors (AChRs) and AChRs aggregates in human muscle cultured in serum-free hormonally/chemically defined medium. Neurology. 36:1986;241.
2. Bodensteiner J.B., Engel A.G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibres in 114 biopsies. Neurology. 28:1978;439-446.
3. Constantin B., Cognard C., Raymond G. Myoblast fusion requires cytosolic calcium elevation but not activation of voltage-dependent calcium channels. Cell Calcium. 19:(5):1997;365-374.
4. Dubrovsky A.L., Corrado A., Bonifati D.M., Pegoraro E., Mesa L. Steroids in muscular dystrophy: where do we stand? Neuromusc. Disord. 8:1998;380-384.
5. Franco-Obregon A., Lansmann J.B. Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J. Physiol. 481:1994;299-309.
6. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
7. Guerriero V., Florim J.R. Stimulation by glucocorticoïd of myoblast growth at low cell densities. Cell. Biol. Int. Rep. 2:(5):1978;441-446.
8. Hardiman O., Brown R.H., Beggs A.H., Specht L., Sklar R.M. Differential glucocorticoïd effects on the fusion of Duchenne/Becker and control muscle cultures. Neurology. 42:1992;1085-1091.
9. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
10. Imbert N., Cognard C., Duport G., Guillou C., Raymond G. Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro. Cell Calcium. 18:1995;177-186.
11. Imbert N., Vandebrouck C., Cognard C., Duport G., Guillou C., Raymond G. Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromusc. Disord. 6:(5):1996;351-360.
12. Leijendekker W.T., Passaquin A.C., Metzinger L., Ruegg U.T. Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br. J. Pharmacol. 118:1996;611-616.
13. Metzinger L., Passaquin A.C., Warter J.M., Poindron P. Alpha-methylprednisolone promotes skeletal myogenesis in dystrophin-deficient and control mouse cultures. Neurosci. Lett. 155:1993;171-174.
14. Metzinger L., Passaquin A., Leijendekker W.J., Poindron P., Ruegg U.T. Modulation by prednisolone of calcium handling in skeletal muscle cells. Br. J. Pharmacol. 116:1995;2811-2816.
15. Pasquini F., Guerin C., Blake D., Davies K., Karpati G., Holland P. The effect of glucocorticoïds on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells. Neuromusc. Disord. 5:1995;105-114.
16. Passaquin A., Metzinger L., Leger J.J., Warter I.M., Poindron P. Predinsolone enhances myogenesis and dystrophin-related protein in skeletal muscle cell cultures from mdx mouse. J. Neurol. Res. 35:1993;363-372.
17. Passaquin A.C., Bouri K., Metzinger L., Coupin G., Warter J.M., Poindron P. Differentiation of C2 skeletal muscle cells is enhanced by α-methylprednisolone. Int. J. Immunopathol. Pharmacol. 7:1994;37-45.
18. Passaquin A.C., Lhote P., Ruegg U.T. Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br. J. Pharmacol. 124:1998;1751-1759.
19. Rifai Z., Welle S., Moxley R.T., Lorenson M., Griggs R.C. Effect of prednisone on protein metabolism in Duchenne dystrophy. Am. J. Physiol. 268:1995;E67-E74.
20. Rivet-Bastide M., Imbert N., Cognard C., Duport G., Rideau Y., Raymond G. Changes in cytosolic resting ionized calcium level and in calcium transients during in vitro development of normal and Duchenne muscular dystrophy cultured skeletal muscle measured by laser cytofluorimetry using Indo-1. Cell Calcium. 14:1993;563-571.
21. Sansome A., Royston P., Dubowitz V. Steroids in Duchenne muscular dystrophy: pilot study of a new low-dosage schedule. Neuromusc. Disord. 5:1993;233-241.
22. Sklar R.M., Brown R.H. Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro. J. Neurol. Sci. 101:1991;73-81.